1.Correlation between peripheral blood mitochondrial DNA and urine microalbumin in patients with type 2 diabetes mellitus
Da CHEN ; Juli ZENG ; Chenxia ZHOU ; Ziyi LI ; Bo FENG ; Jun SONG
Chinese Journal of Diabetes 2025;33(4):248-251
Objective To explore the relationship between peripheral blood mitochondrial DNA(mtDNA)copy number and urinary microalbumin(MAlb)in patients with type 2 diabetes mellitus(T2DM).Methods 87 patients with T2DM from the Endocrinology Department of East Hospital of Tongji University were selected based on inclusion criteria.According to urinary MAlb levels,patients were divided into T2DM group(MAlb<30 mg/L)and MAlb group(MAlb>30 mg/L).General patient information was collected,and clinical indicators such as blood glucose,lipid profile,glycated hemoglobin and insulin were measured.Peripheral blood mtDNA was extracted and the copy number was detected using real-time quantitative polymerase chain reaction(RT-PCR).Logistic regression analysis was used to identify the risk factors for albuminuria.Results Compared with T2DM group,DM duration,serum creatinine,serum uric acid and copy number of mtDNA in MAlb group increased(P<0.05),while high density lipoprotein cholesterol decreased(P<0.05).Logistic analysis showed that the copy number of mtDNA was the influencing factor of MAlb in T2DM patients.Conclusions The peripheral blood mtDNA copy number in T2DM patients is positively correlated with urinary microalbumin,thus providing a potential target for early detection of DKD.
2.Efficacy comparison between tenofovir disoproxil fumarate versus tenofovir alafenamide fumarate treatment in chronic hepatitis B patients with high viral load
Chenxia ZHANG ; Diwen SHI ; Xinyue CHEN ; Yaping DAI ; Yan QI ; Xueshi ZHOU ; Yuanwang QIU
Chinese Journal of Infectious Diseases 2025;43(9):530-536
Objective:Comparative efficacy and safety profiles of tenofovir disoproxil fumarate (TDF) versus tenofovir alafenamide fumarate (TAF) in chronic hepatitis B (CHB) patients with high viral load.Methods:CHB patients with high viral load (hepatitis B virus (HBV) DNA>7 lg IU/mL) receiving TDF ( n=155) or TAF ( n=157) monotherapy were included between December 1st, 2022 and December 1st, 2023, to compare the rates of undetectable HBV DNA (<20 IU/mL), the alanine transaminase (ALT) normalization rate, hepatitis B e antigen (HBeAg) seroconversion rate, renal function and lipid profiles at 48 weeks of treatment. The statistical analysis was performed by the two independent samples t test, Mann-Whitney U test, chi-square test or Fisher′s exact probability test. Results:At week 48 of treatment, the TDF group achieved significantly higher HBV DNA undetectability rates (49.03%(76/155) vs 29.30%(46/157)) and greater mean reduction ((6.05±0.81) lg IU/mL vs (5.57±1.02) lg IU/mL) than the TAF group ( χ2=12.75, t=-4.65, both P<0.001). The ALT normalization rate of patients in the TDF and TAF groups were 77.19%(88/114) and 72.50%(87/120), and HBeAg seroconversion rates were 4.00%(6/150) and 2.67%(4/150), respectively, with no statistically significant differences between the two groups (all P>0.05). The differences in the changes and abnormal rates of serum creatinine and estimated glomerular filtration rate between the two groups of patients were not statistically significant (both P>0.05). The magnitude of decrease (0.15(-0.02, 0.38) mmol/L vs 0.06(-0.06, 0.20) mmol/L) and abnormal rate (27.73%(33/119) vs 16.39%(20/122)) in high-density lipoprotein cholesterol in the TDF group was higher than those in the TAF group, while the increases in low-density lipoprotein cholesterol (-0.09(-0.39, 0.25) mmol/L vs 0.05(-0.31, 0.42) mmol/L), total cholesterol (TC) (-0.23(-0.75, 0.23) mmol/L vs 0.08(-0.35, 0.57) mmol/L), and triglyceride (-0.12(-0.40, 0.06) mmol/L vs 0.00(-0.19, 0.24) mmol/L), as well as the abnormal rate of TC (4.31%(5/116) vs 15.75%(20/127)), in the TDF group were lower than those in the TAF group ( Z=-3.19, χ2=4.51, Z=2.17, Z=4.09, Z=3.71, χ2=8.59, all P<0.05). Conclusion:TDF demonstrated superior efficacy and better safety profiles compared to TAF in high viral load CHB patients.
3.Correlation between peripheral blood mitochondrial DNA and urine microalbumin in patients with type 2 diabetes mellitus
Da CHEN ; Juli ZENG ; Chenxia ZHOU ; Ziyi LI ; Bo FENG ; Jun SONG
Chinese Journal of Diabetes 2025;33(4):248-251
Objective To explore the relationship between peripheral blood mitochondrial DNA(mtDNA)copy number and urinary microalbumin(MAlb)in patients with type 2 diabetes mellitus(T2DM).Methods 87 patients with T2DM from the Endocrinology Department of East Hospital of Tongji University were selected based on inclusion criteria.According to urinary MAlb levels,patients were divided into T2DM group(MAlb<30 mg/L)and MAlb group(MAlb>30 mg/L).General patient information was collected,and clinical indicators such as blood glucose,lipid profile,glycated hemoglobin and insulin were measured.Peripheral blood mtDNA was extracted and the copy number was detected using real-time quantitative polymerase chain reaction(RT-PCR).Logistic regression analysis was used to identify the risk factors for albuminuria.Results Compared with T2DM group,DM duration,serum creatinine,serum uric acid and copy number of mtDNA in MAlb group increased(P<0.05),while high density lipoprotein cholesterol decreased(P<0.05).Logistic analysis showed that the copy number of mtDNA was the influencing factor of MAlb in T2DM patients.Conclusions The peripheral blood mtDNA copy number in T2DM patients is positively correlated with urinary microalbumin,thus providing a potential target for early detection of DKD.
4.Efficacy comparison between tenofovir disoproxil fumarate versus tenofovir alafenamide fumarate treatment in chronic hepatitis B patients with high viral load
Chenxia ZHANG ; Diwen SHI ; Xinyue CHEN ; Yaping DAI ; Yan QI ; Xueshi ZHOU ; Yuanwang QIU
Chinese Journal of Infectious Diseases 2025;43(9):530-536
Objective:Comparative efficacy and safety profiles of tenofovir disoproxil fumarate (TDF) versus tenofovir alafenamide fumarate (TAF) in chronic hepatitis B (CHB) patients with high viral load.Methods:CHB patients with high viral load (hepatitis B virus (HBV) DNA>7 lg IU/mL) receiving TDF ( n=155) or TAF ( n=157) monotherapy were included between December 1st, 2022 and December 1st, 2023, to compare the rates of undetectable HBV DNA (<20 IU/mL), the alanine transaminase (ALT) normalization rate, hepatitis B e antigen (HBeAg) seroconversion rate, renal function and lipid profiles at 48 weeks of treatment. The statistical analysis was performed by the two independent samples t test, Mann-Whitney U test, chi-square test or Fisher′s exact probability test. Results:At week 48 of treatment, the TDF group achieved significantly higher HBV DNA undetectability rates (49.03%(76/155) vs 29.30%(46/157)) and greater mean reduction ((6.05±0.81) lg IU/mL vs (5.57±1.02) lg IU/mL) than the TAF group ( χ2=12.75, t=-4.65, both P<0.001). The ALT normalization rate of patients in the TDF and TAF groups were 77.19%(88/114) and 72.50%(87/120), and HBeAg seroconversion rates were 4.00%(6/150) and 2.67%(4/150), respectively, with no statistically significant differences between the two groups (all P>0.05). The differences in the changes and abnormal rates of serum creatinine and estimated glomerular filtration rate between the two groups of patients were not statistically significant (both P>0.05). The magnitude of decrease (0.15(-0.02, 0.38) mmol/L vs 0.06(-0.06, 0.20) mmol/L) and abnormal rate (27.73%(33/119) vs 16.39%(20/122)) in high-density lipoprotein cholesterol in the TDF group was higher than those in the TAF group, while the increases in low-density lipoprotein cholesterol (-0.09(-0.39, 0.25) mmol/L vs 0.05(-0.31, 0.42) mmol/L), total cholesterol (TC) (-0.23(-0.75, 0.23) mmol/L vs 0.08(-0.35, 0.57) mmol/L), and triglyceride (-0.12(-0.40, 0.06) mmol/L vs 0.00(-0.19, 0.24) mmol/L), as well as the abnormal rate of TC (4.31%(5/116) vs 15.75%(20/127)), in the TDF group were lower than those in the TAF group ( Z=-3.19, χ2=4.51, Z=2.17, Z=4.09, Z=3.71, χ2=8.59, all P<0.05). Conclusion:TDF demonstrated superior efficacy and better safety profiles compared to TAF in high viral load CHB patients.
5.Role of lipophagy in the prevention and treatment of nonalcoholic fatty liver disease
Zhili XIAO ; Chenxia LU ; Danni ZHOU ; Zhuangzhuang CHEN ; Mingzhong XIAO ; Xiaodong LI
Journal of Clinical Hepatology 2024;40(7):1450-1458
Nowadays,the prevalence of nonalcoholic fatty liver disease(NAFLD)is constantly rising in China and globally,and its incidence rate is increasing year by year,which has seriously affected human life and health.Lipophagy is molecular chaperone-mediated autophagy and has the functions of promoting lipolysis,maintaining the lipid homeostasis of hepatocytes,and alleviating hepatocyte fatty degeneration.Lipophagy has three main processes of lipid droplet catabolism,lipid droplet autophagy,and fatty acid β-oxidation,which are regulated by key genes,receptors,and enzymes.Currently,important advances have been achieved for the intervention methods of traditional Chinese medicine,Western medicine,diet,and exercise in the research on lipophagy,which provides new perspectives for the prevention and treatment strategies for NAFLD.
6.Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke.
Lu LIU ; Chenxia ZHOU ; Huimin JIANG ; Huimin WEI ; Yifan ZHOU ; Chen ZHOU ; Xunming JI
Frontiers of Medicine 2023;17(6):1047-1067
The Coronavirus disease 2019 (COVID-19) epidemic has triggered a huge impact on healthcare, socioeconomics, and other aspects of the world over the past three years. An increasing number of studies have identified a complex relationship between COVID-19 and stroke, although active measures are being implemented to prevent disease transmission. Severe COVID-19 may be associated with an increased risk of stroke and increase the rates of disability and mortality, posing a serious challenge to acute stroke diagnosis, treatment, and care. This review aims to provide an update on the influence of COVID-19 itself or vaccines on stroke, including arterial stroke (ischemic stroke and hemorrhagic stroke) and venous stroke (cerebral venous thrombosis). Additionally, the neurovascular mechanisms involved in SARS-CoV-2 infection and the clinical characteristics of stroke in the COVID-19 setting are presented. Evidence on vaccinations, potential therapeutic approaches, and effective strategies for stroke management has been highlighted.
Humans
;
COVID-19/complications*
;
SARS-CoV-2
;
Stroke/therapy*
7.An artificial intelligence-based system for measuring the size of gastrointestinal lesions under endoscopy (with video)
Jing WANG ; Xi CHEN ; Lianlian WU ; Wei ZHOU ; Chenxia ZHANG ; Renquan LUO ; Honggang YU
Chinese Journal of Digestive Endoscopy 2022;39(12):965-971
Objective:To develop an artificial intelligence-based system for measuring the size of gastrointestinal lesions under white light endoscopy in real time.Methods:The system consisted of 3 models. Model 1 was used to identify the biopsy forceps and mark the contour of the forceps in continuous pictures of the video. The results of model 1 were submitted to model 2 and classified into open and closed forceps. And model 3 was used to identify the lesions and mark the boundary of lesions in real time. Then the length of the lesions was compared with the contour of the forceps to calculate the size of lesions. Dataset 1 consisted of 4 835 images collected retrospectively from January 1, 2017 to November 30, 2019 in Renmin Hospital of Wuhan University, which were used for model training and validation. Dataset 2 consisted of images collected prospectively from December 1, 2019 to June 4, 2020 at the Endoscopy Center of Renmin Hospital of Wuhan University, which were used to test the ability of the model to segment the boundary of the biopsy forceps and lesions. Dataset 3 consisted of 302 images of 151 simulated lesions, each of which included one image of a larger tilt angle (45° from the vertical line of the lesion) and one image of a smaller tilt angle (10° from the vertical line of the lesion) to test the ability of the model to measure the lesion size with the biopsy forceps in different states. Dataset 4 was a video test set, which consisted of prospectively collected videos taken from the Endoscopy Center of Renmin Hospital of Wuhan University from August 5, 2019 to September 4, 2020. The accuracy of model 1 in identifying the presence or absence of biopsy forceps, model 2 in classifying the status of biopsy forceps (open or closed) and model 3 in identifying the presence or absence of lesions were observed with the results of endoscopist review or endoscopic surgery pathology as the gold standard. Intersection over union (IoU) was used to evaluate the segmentation effect of biopsy forceps in model 1 and lesion segmentation effect in model 3, and the absolute error and relative error were used to evaluate the ability of the system to measure lesion size.Results:(1)A total of 1 252 images were included in dataset 2, including 821 images of forceps (401 images of open forceps and 420 images of closed forceps), 431 images of non-forceps, 640 images of lesions and 612 images of non-lesions. Model 1 judged 433 images of non-forceps (430 images were accurate) and 819 images of forceps (818 images were accurate), and the accuracy was 99.68% (1 248/1 252). Based on the data of 818 images of forceps to evaluate the accuracy of model 1 on judging the segmentation effect of biopsy forceps lobe, the mean IoU was 0.91 (95% CI: 0.90-0.92). The classification accuracy of model 2 was evaluated by using 818 forceps pictures accurately judged by model 1. Model 2 judged 384 open forceps pictures (382 accurate) and 434 closed forceps pictures (416 accurate), and the classification accuracy of model 2 was 97.56% (798/818). Model 3 judged 654 images containing lesions (626 images were accurate) and 598 images of non-lesions (584 images were accurate), and the accuracy was 96.65% (1 210/1 252). Based on 626 images of lesions accurately judged by model 3, the mean IoU was 0.86 (95% CI: 0.85-0.87). (2) In dataset 3, the mean absolute error of systematic lesion size measurement was 0.17 mm (95% CI: 0.08-0.28 mm) and the mean relative error was 3.77% (95% CI: 0.00%-10.85%) when the tilt angle of biopsy forceps was small. The mean absolute error of systematic lesion size measurement was 0.17 mm (95% CI: 0.09-0.26 mm) and the mean relative error was 4.02% (95% CI: 2.90%-5.14%) when the biopsy forceps was tilted at a large angle. (3) In dataset 4, a total of 780 images of 59 endoscopic examination videos of 59 patients were included. The mean absolute error of systematic lesion size measurement was 0.24 mm (95% CI: 0.00-0.67 mm), and the mean relative error was 9.74% (95% CI: 0.00%-29.83%). Conclusion:The system could measure the size of endoscopic gastrointestinal lesions accurately and may improve the accuracy of endoscopists.
8.Analysis of the Application of TCM Injection in 3 Hospitals from Jiangsu Changshu during 2013 to 2015
Li ZHANG ; Guifen ZHANG ; Chenxia ZHOU
China Pharmacy 2016;27(35):4913-4916
OBJECTIVE:To provide reference for rational use of TCM injection in the clinic. METHODS:In retrospective survey,the application of TCM injections in 3 hospitals from Changshu area during 2013-2015 were analyzed statistically in re-spects of consumption sum,annual growth rate,constituent ratio,DDDs,B/A,DDC,etc. RESULTS:During 2013-2015,in the sample hospitals,consumption sum of TCM injections in 2014 and 2015 declined by 5.27% and 15.92%,compared with last year. The proportion of consumption sum of TCM injections in total consumption sum were 4.40% in 2013,3.86% in 2014 and 3.13%in 2015. Top 3 TCM injections in the list of consumption sum and DDDs were blood activating and stasis eliminating drugs,the re-suscitation and reviving yang first aid class drugs and tonic drugs. The top single types in the list of consumption sum were Xing-naojing injection,Shuxuetong injection,Xuebijing injection,Shenmai injection and Xue shuantong for injection;the top single types in the list of DDDs were Shenmai injection,Reduning injection,Shuxuetong for injection,etc. B/A of Shenmai injection and Reduning injection were higher,while DDC of Xuebijing injection was the highest. CONCLUSIONS:The utilization of TCM injec-tion is basically reasonable,and shows decreasing tendency in sample hospitals,but great importance should be attached to the safe-ty and effectiveness of TCM injections and reasonable choice.
9.Correlation between the types of the constitution in TCM and the sleep status in PLA Navy divers
Ding TIAN ; Rong LIANG ; Ying TANG ; Jie MA ; Jing GUAN ; Fengzhi WU ; Chenxia HAN ; Mengling ZHOU ; Feng LI
International Journal of Traditional Chinese Medicine 2015;(8):686-690
Objective To investigate the correlation between the types of constitution in TCM and the sleep status in the PLA Navy divers. Methods Eighty-nine PLA Navy divers who performed 10m diving professional training were selected. Constitution in TCM was classified and determined by the standardized standard Constitution in Chinese Medicine Questionnaire, sleep status was evaluated by the Pittsburgh Sleep Quality Index. Results 62.9% of Navy divers were the mild constitution in TCM. The eight kinds of the biased constitution in TCM are ranked with yang deficiency, phlegm-dampness, dampness-heat, qi deficiency, yin deficiency, blood stasis, qi stagnation and special intrinsic quality. Among 78 Navy divers with good sleep quality, there were 49 divers (72.1%) with the mild constitution in TCM and 19 (27.9%) with the biased constitution in TCM. Among 21 Navy divers with poor sleep quality, there were 7 divers (33.3%) with the mild constitution in TCM (accounting for) and 14 (66.7%) with the biased constitution in TCM. For Navy divers with poor sleep quality, the sleep quality scores were positive correlated with the blood stasis constitution in TCM (r=0.481,P<0.05). Conclusion Sleep status is correlated with the types of the constitution in TCM, and regulating constitution in TCM can improve sleep quality in PLA Navy divers.
10.Efficacy of Rehabilitation on Memory Disorders
Mingming GAO ; Xiaoping YUN ; Huili ZHANG ; Huazhen GUO ; Xin ZHANG ; Xiulian NIU ; Xin QI ; Yingxin QIAO ; Jianwen WANG ; Chenxia GUAN ; Fuying LI ; Hai REN ; Ye LIU ; Yajuan LU ; Baohua XU ; Ruowei ZHOU
Chinese Journal of Rehabilitation Theory and Practice 2011;17(6):527-530
Objective To investigate the effect of rehabilitation on memory deficits after acquired brain injury, to compare different training models of memory rehabilitation and to analyze the possible factors affecting memory rehabilitation. Methods 144 patients with acquired brain injury following memory deficits were randomly assigned to computer-assisted training group, face-to-face training group and control group. Both training groups were given memory-based cognitive training program once a day which sustained 30 minutes for 6 or 12 weeks. The instantaneous memory, short-term memory and long-term memory were evaluated and compared before and after training. The effect of gender, age, education, course, site of injury and coma time on training efficacy were analyszed as well. Results 6 weeks and 12 weeks at training, both computer-assisted and face-to-face training groups showed a significant improvement in memory abilities when compared to controls (P<0.01), with the former making more progress (P<0.01). Negative correlation was found between age and memory performance. Conclusion Effectiveness of memory rehabilitation is proven. 12 weeks training can significantly improve memory. Cognitive training using professional equipment is significantly more effective than the face-to-face training and should be recommended.


Result Analysis
Print
Save
E-mail